Drug Profile
Research programme: IgE antibody therapeutics - Epsilogen
Alternative Names: IGEM Ch; IGEM E; IGEM FR; IGEM H; IGEM PLatest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Kings College London
- Developer Epsilogen
- Class Antibodies; Antineoplastics; Immunoglobulins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours